By Sheri Kasprzak
New York, Sept. 29 - Resonance Health Ltd. said it has wrapped a A$1 million private placement.
The company sold 8,695,652 shares at A$0.115 each to institutional and sophisticated investors.
Tolhurst & Noall was the placement agent for the deal.
Resonance also said it has instituted a share purchase plan for its shareholders for up to A$5,000. The shares will be sold at A$0.115 each.
Proceeds from both the private placement and the share purchase plan will be used to accelerate the company's rollout of its Ferriscan test.
Based in Nederlands, Western Australia, Resonance develops magnetic resonance imaging technologies to measure iron levels in the body.
| Issuer: | Resonance Health Ltd.
|
| Issue: | Stock
|
| Amount: | A$1 million
|
| Shares: | 8,695,652
|
| Price: | A$0.115
|
| Warrants: | No
|
| Placement agent: | Tolhurst & Noall
|
| Settlement date: | Sept. 29
|
| Stock price: | A$0.13 at close Sept. 29
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
